Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Weifang Zeng
Sichuan Haisco Pharmaceutical Co Ltd
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
49
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Safety and Effectiveness of HSK21542 for Hemodialysis Patients: A Multiple Ascending Dose Study
Number of pages: 34
Posted: 03 Feb 2023
mingming pan
,
Gui-Hua Wang
,
Li Zhou
,
Yan Xu
,
Yao Li
,
Chaoqing Wu
,
Changlin Mei
,
Zhanzheng Zhao
,
Dong Sun
,
Tianjun Guan
,
Qinkai Chen
,
Ming Shi
,
Hui Xu
, Weifang Zeng,
Fangqiong Li
,
Rui Yan
and
Bi-Cheng Liu
Southeast University - Institute of Nephrology, Southeast University - Institute of Nephrology, Sichuan University - Kidney Research Institute, Qingdao University - Department of Nephrology, China Medical University - Department of Nephrology, People’s Hospital of Guangxi Zhuang Autonomous Region - Department of Nephrology, Government of the People's Republic of China - Kidney Institute, Zhengzhou University - Department of Nephrology, Xuzhou Medical University - Department of Nephrology, Xiamen University - Division of Nephrology, Nanchang University - Department of Nephrology, Wuhan University - Department of Nephrology, Central South University - Division of Nephrology, Sichuan Haisco Pharmaceutical Co Ltd, Sichuan Haisco Pharmaceutical Co Ltd, Guizhou Medical University (Guiyang Medical University) - Department of Nephrology and Southeast University - Institute of Nephrology
Downloads
49
(1,086,013)
View PDF
Download
Abstract:
CKD-aP, HSK21542, hemodialysis, κ-opioid receptor agonist, uremic pruritus
Feedback